December 16, 2013 | Hadasit, the technology transfer company of the Hadassah Medical Center, has signed a $4 million cooperation agreement with Poland’s Synektik SA to develop new imaging agents for non-invasive diagnosis of cardiovascular disease. The imaging agents are for use in PET/ CT scans, enabling physicians to achieve a quantitative measurement of blood flow to the heart.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments